Total flavonoids of Hippophae rhamnoides L. improves type 2 diabetes symptoms in rats through down-regulating of the DAG/PRKCA/MAPK10/p65/TNF-α signalling pathway

J Ethnopharmacol. 2024 Jan 10;318(Pt A):116962. doi: 10.1016/j.jep.2023.116962. Epub 2023 Jul 25.

Abstract

Ethnopharmacological relevance: Dry mature fruits of Hippophae rhamnoides L. (HRL), Elaeagnaceae, have traditional functions of invigorating spleen and improving spleen insufficiency. Traditional Chinese medicine (TCM) clinics have been proved that HRL is in favor of diabetes treatment. Modern pharmacological studies demonstrated that total flavones of Hippophae rhamnoides (TFH) are the main substance for HRL to develop anti-inflammation and anti-diabetes functions. However, chemical features, active ingredients and anti-diabetes pharmacological mechanism of HRL still remain unclear.

Aim of the study: Key targets and metabolites in anti-type-II diabetes mellitus (T2DM) of TFH have been explored based on AGE-RAGE signaling pathway in diabetic complications. The anti-T2DM mechanism of TFH has been elaborated from comprehensive perspectives, including target prediction, metabolites, potential metabolic pathways, and so on.

Materials and methods: In this study, a qualitative test of chemical composition of HRL was carried out based on ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). The anti-T2DM targets and pathways of HRL were predicted through network pharmacological approach. The T2DM rat model was induced by high-fat and high-glucose diet combined with streptozotocin (STZ). The T2DM model was evaluated through fasting blood glucose level, body weight, serum biochemical indicators, insulin levels and homeostatic model assessment of insulin resistance. The key metabolic pathways were screened through the correlation between metabolites and key targets. Finally, the quantitative analysis of key targets and metabolites was verified through experiments.

Results: After TFH intervention, the fasting blood-glucose level of T2DM rats induced by high-fat and high-glucose diet combined with streptozotocin (STZ) was downregulated significantly, while body weight, serum liquid level, insulin levels and homeostatic model assessment of insulin resistance (HOMA-IR) were improved. According to ELISA, Western blotting (WB) and reverse transcriptase polymerase chain reaction (RT-PCR), TFH significantly downregulates expression levels of diglyceride (DAG)-activated protein kinase C (PRKCA), mitogen activated protein kinase 10 (MAPK10), human nuclear factor κB subunit p65 (NF-κB p65) and tumor necrosis factor-α (TNF-α) in pancreas of STZ-induced rats.

Conclusions: TFH downregulates expressions of PRKCA, MAPK10 and p65 TNF-α as well as level of the key metabolite DA in the DAG/PRKCA/MAPK10/TNF-α/p65 pathways, improves lipid metabolism disorder, inhibits inflammatory response and thereby relieves symptoms of T2DM.

Keywords: Hippophae rhamnoides L.; PRKCA; Total flavones of Hippophae rhamnoides; Type 2 diabetes mellitus.

MeSH terms

  • Animals
  • Body Weight
  • Diabetes Mellitus, Type 2* / metabolism
  • Flavonoids / pharmacology
  • Glucose / metabolism
  • Hippophae* / chemistry
  • Humans
  • Insulin Resistance*
  • Insulins* / therapeutic use
  • Mitogen-Activated Protein Kinase 10 / metabolism
  • Protein Kinase C-alpha / metabolism
  • Rats
  • Signal Transduction
  • Streptozocin
  • Tumor Necrosis Factor-alpha

Substances

  • Flavonoids
  • Tumor Necrosis Factor-alpha
  • Mitogen-Activated Protein Kinase 10
  • Streptozocin
  • Glucose
  • Insulins
  • PRKCA protein, human
  • Protein Kinase C-alpha